Inhalation toxicology of ricin preparations: Animal models, prophylactic and therapeutic approaches to protection

Inhalation Toxicology

Volumn 19, Issue 10, 2007, Pages 873-887

  Griffiths, Gareth D ^a   Phillips, Gary J ^a   Holley, Jane ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; LIPOSOME; PLANT TOXIN; POLYGLACTIN; POLYLACTIDE; RECOMBINANT RICIN A VACCINE; RECOMBINANT VACCINE; RICIN; RICIN TOXIN; UNCLASSIFIED DRUG;

AEROSOL; AFFINITY CHROMATOGRAPHY; CLARA CELL; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INHALATION; ISOELECTRIC FOCUSING; LUNG INJURY; LUNG WEIGHT; NONHUMAN; PARTICLE SIZE; PATHOPHYSIOLOGY; PHYTOTOXICITY; PRIORITY JOURNAL; REVIEW; RICINUS COMMUNIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INHALATION EXPOSURE; RICIN;

ANIMALIA; RICINUS COMMUNIS;

EID: 34547760887     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370701432124     Document Type: Review

References (59)

1. Baluna, R., Rizo, J., Gordon, B. E., Ghetie, V., and Vitetta, E. S. 1999. Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proc. Natl. Acad. Sci. USA 96(7):3957-3962.
2. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. 2000. The Protein Data Bank. Nucleic Acids Res. 28:235-242.
3. Brown, R. F. R., and White, D. E. 1997. Ultrastructure of rat lung following inhalation of ricin aerosol. Int. J. Exp. Pathol. 78(4):267-276.
4. Cope, A. C., Dec, J., Cannan, R. K., Renshaw, B., and Moore, S. 1946. Ricin, Summary Technical Report of Division 9 (Chemistry), Chemical warfare agents and related problems, U.S. Defense Office of Science and Development, National Defense Research Committee, Vol. 1, pp. 179-203.
5. Dawson, R. M., Alderton, M. R., Wells, D., and Hartley, P. G. 2006. Monovalent and polyvalent carbohydrate inhibitors of ricin binding to a model of the cell surface receptor. J. Appl. Toxicol. 26(3):247-252.
6. 125I] Ricin in mice following aerosol inhalation exposure. Toxicology 98(1-3):137-149.
7. Endo, Y., and Tsurugi, K. 1987. RNA N-glycosidase activity of ricin A-chain; Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes. J. Biol. Chem. 262(17):8128-8130.
8. Endo, Y., Mitsui, K., Motizuki, M., and Tsurugi, K. 1987. The mechanism of action of ricin and related toxin lectins on eukaryotic ribosomes. The site and characteristics of the modification in 28S ribosomal RNA caused by the toxins, J. Biol. Chem. 262(12):5908-5912.
9. Foxwell, B. M. J., Detre, S. I., Donovan, T. A., and Thorpe, P. E. 1985. The use of anti-ricin antibodies to protect mice intoxicated with ricin. Toxicology 34(1):79-88.
10. Franz, D., and Jaax, N. 1997. Ricin toxin. In Textbook of military medicine: Part I, Medical aspects of chemical and biological warfare, eds. R. Zajtchuk and R. F. Bellamy, pp. 631-642. Washington, DC: Office of the Surgeon General of the Army, TMM Publications.
11. Funatsu, G., Mise, T., Matsuda, H., and Funatsu, M. 1978. Isolation and characterization of two constituent polypeptide chains of ricin E. Agric. Biol. Chem. 42(4):851-859.
12. Griffiths, G. D., Rice, P., Allenby, A. C., Bailey, S. C., and Upshall, D. G.1994. Inhalation toxicology and histopathology of ricin and abrin toxins. Inhal. Toxicol. 7(2):269-288.
13. Griffiths, G. D., Lindsay, C. D., Allenby, A. C., Bailey, S. C., Scawin, J. W., Rice, P., and Upshall, D. G. 1995. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum. Exp. Toxicol. 14(2):155-164.
14. Griffiths, G. D., Bailey, S. C., Hambrook, J. L., Keyte, M., Jayasekera, P., Miles, J., and Williamson, E. 1997. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Vaccine 15(17-18):1933-1939.
15. Griffiths, G. D., Bailey, S. C., Hambrook, J. L., and Keyte, M. 1998. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine 16(5):530-535.
16. Griffiths, G. D., Phillips, G. J., and Bailey, S. C. 1999. Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation. Vaccine 17(20-21):2562-2568.
17. Guo, J.-W., Shen, B.-F., Feng, J.-N., Sun, Y.-X., Yu, M., and Hu, M.-R. 2005. A novel neutralizing monoclonal antibody against cell bindingpolypeptide of ricin. Hybridoma (Larchmt.) 24(5):263-266.
18. Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., and Stahlhofen, W. 1986. Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J. Aerosol. Sci., 17(5):811-825.
19. Ishiguro, M., Takahashi, T., Funatsu, G., Hayashi, K., and Funatsu, M. 1964. Biochemical studies on Ricin I. Purification of ricin. J. Biochem. (Tokyo) 55:587-592.
20. Kende, M., Yan, C., Hewetson, J., Frick, M. A., Rill, W. L., and Tammariello, R. 2002. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 20(11-12):1681-1691.
21. Kende, M., Del Giudice, G., Rivera, N., and Hewetson, J. 2006. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine 24(12):2213-2221.
22. Kende, M., Tan, X., Wlazlowski, C., Williams, R., Lindsey, C., and Del Giudice, G. 2007. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by mucosal adjuvants LTK63 and LTR72. Vaccine 25(16):3219-3227.
23. Lee, C., Watt, K. C., Chang, A. M., Plopper, C. G., Buckpitt, A. R., and Pinkerton, K. E. 1998. Site selective differences in cytochrome P450 isoform activities. Comparison of expression in rat and rhesus monkey lung and induction in rats. Drug. Metab. Dispos. 26(5):396-400.
24. Leong, K. H., Wang, H. C., Stukel, J. J., and Hopke, P. K. 1982. An improved constant output atomiser. Am. Ind. Hyg. Assoc. J. 43:135-136.
25. Lin, J. Y., Liu, K., Chen, C.-C., and Tung, T.-C. 1971. Effect of crystalline ricin on the biosynthesis of protein, RNA and DNA in experimental tumor cells. Cancer Res. 31(7):921-924.
26. Lin, T. T.-S., and Li, S. S.-L. 1980. Purification and physicochemical properties of ricins and agglutinins from Ricinus communis. Eur. J. Biochem. 105(3):453-459.
27. Liu, B. Y. H., and Lee, K. W. 1975. An aerosol generator of high stability Am. Ind. Hyg. Assoc. J. 36(12):861-865.
28. Lord, J. M., Gould, J., Griffiths, D., O'Hare, M., Prior, B., Richardson, P. T., and Roberts, L. M. 1987. Ricin: Cytotoxicity, biosynthesis and use in immunoconjugates. Prog. Med. Chem. 24:1-28.
29. Lord, J. M., Hartley, M. R., and Roberts, L. M. 1991. Ribosome inactivating proteins in plants. Semin. Cell Biol. 2(1):15-22.
30. Lord, J. M., Roberts, L. M., and Lencer, W. I. 2005. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: Co-opting basic mechanisms of endoplasmic reticululm-associated degradation. Curr. Top. Microbiol. Immunol. 300:149-168.
31. Marsden, C. J., Knight, S., Smith, D. C., Day, P. J., Roberts, L. M., Phillips, G. J., and Lord, J. M. 2004. Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine. Vaccine 22(21-22):2800-2805.
32. Mise, T., Funatsu, G., Ishiguro, M., and Funatsu, M. 1977. Isolation and characterization of ricin E from castor beans. Agric. Biol. Chem. 41(10):2041-2046.
33. Nicolson, G. L., and Blaustein, J. 1972. The interaction of Ricinus communis agglutinin with normal and tumour cell surfaces. Biochim. Biophys. Acta 266(2):543-547,
34. Olsnes, S., and Pihl, A. 1976. Abrin, ricin and their associated agglutinins. In The specificity and action of animal, bacterial and plant toxins: Receptors and recognition, Series B, Vol. 1, ed. P. Cuatrecasas, pp. 129-173. London: Chapman and Hall.
35. Olsnes, S., and Pihl, A. 1982. Toxic lectins and related proteins. In Molecular action of toxins and viruses, eds. P. Cohen and S. van Heyningen, pp. 51-105. Amsterdam: Elsevier.
36. Olson, M. A., Carra, J. H., Roxas-Duncan, V., Wannemacher, R. W., Smith, L. A., and Millard, C. B. 2004. Finding a new vaccine in the ricin protein fold. Protein Eng. Des. Sel. 17(4):391-397.
37. Paddle, B. M. 2003. Therapy and prophylaxis of inhaled biological toxins (Review article). J. Appl. Toxicol. 23(3):139-170.
38. Perentesis, J. P., Miller, S. P., and Bodley, J. W. 1992. Protein toxic inhibitors of protein synthesis. Biofactors 3(3):173-184.
39. Phillips, G. J., Knight, S., Hornby, R., Wilkinson, L., Platt, J., Hughes, N., and Griffiths, G. In preparation. Comparison of the protective efficacies of several ricin vaccine candidates: Immunological characterisation and quality of protection.
40. Plopper, C. G., and Harkema, J. R. 2005. Respiratory system. In The laboratory primate handbook of experimental animals, ed. S. Woolfe-Coote, pp. 503-522. London: Elsevier Academic Press.
41. Poli, M. A., Rivera, V. R., Pitt, M. L., and Vogel, P.1996. Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure. Toxicon 34(9):1037-1044.
42. Poole, S. J. C., Veall, S. M., Holley, J. L., and Simpson, A. J. H. 2006. The production and evaluation of ricin antitoxins. Toxicon.
43. Raabe, O. G., Al-Bayati, M., Teague, S. V., and Rasolt, A. 1988. Regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals. Ann. Occup. Hyg. 32(suppl. 1):53-63.
44. Roy, C. J., Hale, M., Hartings, J. M., Pitt, L., and Duniho, S. 2003. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal. Toxicol. 15(6):619-638.
45. Rutenber, E., Katzin, B. J., Ernst, S., Collins, E. J., Mlsna, D., Ready, M. P., and Robertus, J. D. 1991. Crystallographic refinement of ricin to 2.5 angstroms. Proteins Struct. Funct. 10:240-259.
46. Schreider, J. P. 1983. Nasal airway anatomy and inhalation deposition in experimental animals and people. In Nasal tumours in animals and man, Vol. III. Experimental nasal carcinogenesis, eds. G. Reznik and S. F. Stinson, pp. 1-26. Boca Raton, FL: CRC Press.
47. Sipes, I. G., and Gandolfi, A. J. 1991. Biotransformation of toxicants. In Casarett and Doull's toxicology; The basic science of poisons, 4th ed., eds. M. O. Amdur, J. Doull, and C. D. Klaassen, pp. 88-126, Pergamon Press.
48. Smallshaw, J. E., Firan, A., Fulmer, J. R., Ruback, S. L., Ghetie, V., and Vitetta, E. S. 2002. A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine 20(27-28):3422-3427.
49. Smallshaw, J. E., Ghetie, V., Rizo, J., Fulmer, J. R., Trahan, L. L., Ghetie, M. A., and Vitetta, E. S. 2003. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nat. Biotechnol. 21(4):387-391.
50. Smallshaw, J. E., Richardson, J. A., Pincus, S., Schindler, J., and Vitetta, E. S. 2005. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine 23(39):4775-4784.
51. Soler-Rodriguez, A. M., Ghetie, M. A., Oppenheimer-Marks, N., Uhr, J. W., and Vitetta, E. S. 1993. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: Implications for vascular leak syndrome. Exp. Cell Res. 206(2):227-234.
52. Stirpe, F., and Battelli, M. G. 2006. Ribosome-inactivating proteins: progress and problems. Cell. Mol. Life Sci. 63(16):1850-1866.
53. Stirpe, F., and Barbieri, L. 1986. Ribosome-inactivating proteins to date. FEBS Lett. 195(1-2):1-8.
54. Stirpe, F., Barbieri, L., Batelli, M. G., Soria, M., and Lappi, D.A. 1992. Ribosome-inactivating proteins from plants: Present status and future prospects. Biotechnology (NY) 10(4):405-412.
55. Vitetta, E. S., Smallshaw, J. E., Coleman, E., Jafri, H., Foster, C., and Munford, R. A. 2006. Pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc. Natl. Acad. Sci. USA 103:2268-2273.
56. Wang, S., Feng, J., Guo, J., Guo, Leiming, G., Li, Y., Sun, Y., Qin, W., Hu, M., Han, G., and Shen, B. 2006. A novel designed single domain antibody on 3-D structure of ricin A chain remarkably blocked ricin-induced cytotoxicity. Mol. Immunol. 43:1912-1919.
57. Wannemacher, R. W., and Anderson, J. B. 2006. Inhalation ricin: Aerosol procedures, toxicology and therapy. In Inhalation toxicology, 2nd ed., eds. H. Salem and S. Katz, pp. 973-980. Boca Raton, FL: CRC Taylor & Francis.
58. Wilhelmsen, C. L., and Pitt, M. L. M. 1996. Lesions of acute inhaled lethal ricin intoxication in rhesus monkeys. Vet. Pathol. 33(3):296-302.
59. Yan, C., Rill, W. L., Malli, R., Hewetson, J., Naseem, H., Tammariello, R., and Kende, M. 1996. Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. Vaccine 14(11):1031-1038.